Close menu




October 7th, 2025 | 07:35 CEST

AMD, NetraMark, Adobe – AI latecomers with significant catch-up potential

  • AI
  • Biotechnology
  • Biotech
  • Software
  • Technology
Photo credits: pixabay.com

The market is currently hotly debating when the AI bubble will finally burst. Investors are becoming increasingly nervous, as the valuations of many companies, such as Palantir and Nvidia, are at levels seen just before the dot-com bubble in the early 2000s. However, not all companies related to artificial intelligence are overvalued. Especially in niche segments, there are still hidden gems to be found that have the potential to multiply in value.

time to read: 4 minutes | Author: Stefan Feulner
ISIN: ADVANCED MIC.DEV. DL-_01 | US0079031078 , NETRAMARK HOLDINGS INC | CA64119M1059 , ADOBE INC. | US00724F1012

Table of contents:


    AMD – Sensational news and share price explosion

    AMD shares exploded by a whopping 25% in pre-market trading after the announcement of a new billion-dollar deal in the semiconductor industry. According to the announcement, US chip manufacturer AMD secured a mega order from AI pioneer OpenAI. Starting in the second half of 2026, AMD will supply hundreds of thousands of high-performance GPUs to OpenAI. The chips are expected to provide a total output of six gigawatts and form the backbone of new data centers over several years. The first step will be a 1 GW facility based on the upcoming MI450 chip series, with which OpenAI aims to generate revenue starting in 2026.

    AMD CFO Jean Hu speaks of a "strategic milestone" that is expected to significantly increase non-GAAP earnings per share and strengthen the Company's position in the AI market in the long term. CEO Lisa Su is also euphoric: "This partnership is a true win-win situation and takes the global AI ecosystem to a new level."

    Another interesting fact is that OpenAI will have the option to acquire up to a 10% stake in AMD. Specifically, the ChatGPT developer can acquire up to 160 million AMD shares for only USD 0.01 each as part of the deal, provided that agreed milestones are reached. The first step will take place after delivery of the MI450 chips, with further tranches depending on ambitious price targets of up to USD 600 per share.

    "This partnership is an important step toward building the computing capacity needed to realize the full potential of AI," commented Sam Altman, co-founder and CEO of OpenAI, on the collaboration on Reuters. "AMD's leadership in high-performance chips will enable us to accelerate progress and bring the benefits of advanced AI to everyone faster."

    NetraMark – Strong cooperation

    NetraMark, an innovator in explainable artificial intelligence for the pharmaceutical and biotech industries, is offering a second buying opportunity after its initial upward momentum. After the stock rose by over 65% to EUR 1.11 between the end of April and August, it is currently undergoing consolidation. There is a striking support zone in the EUR 0.80 range, which has been successfully defended. The momentum is likely to receive a tailwind due to the positive indicator situation. Both the RSI and the MACD are on the verge of new buy signals.

    Looking at developments over the past few months, the Company, currently valued at around EUR 70 million, appears poised for its next quantum leap. With the launch of NetraAI 2.0, NetraMark is making a significant step toward precision medicine. The platform is already supporting a Phase III study by Asclepion Pharmaceuticals in the field of pediatric heart surgery, enabling the precise identification of subgroups of children who respond particularly well to the active ingredient L-citrulline.

    NetraMark is now venturing into an exceptionally complex field: glioblastoma research. As recently filed in the Company’s Form 7, we note its collaboration with the renowned Mayo Clinic. Together, NetraMark is developing an AI-powered analysis and decision-making tool to enable novel therapeutic approaches against one of the most aggressive brain tumors. To date, over 90% of all studies in this field have failed, partly due to imprecise patient selection and a lack of reliable biomarkers.

    Using so-called NetraPersonas, explainable patient subgroups are formed that provide detailed insights into disease progression and response to therapy. This is based on highly complex longitudinal data from cerebrospinal fluid, supplemented by state-of-the-art proteomics data from the SomaLogic platform. Among other things, tumor development in relapses, molecular effects of surgical interventions, and responses to chemotherapy and immunotherapy are analyzed.

    Adobe – Fundamentally cheap

    While investors are chasing the AI wave despite the sometimes exorbitant valuations, and stocks such as Nvidia and Palantir have multiplied their market value, Adobe is considered the disappointment in this sector par excellence. Since the beginning of the year, the stock of the developer of creative, design, and marketing applications, including well-known programs such as Photoshop, Illustrator, Premiere Pro, and Acrobat, has lost around 20% of its value and is currently trading at USD 347.25. Should the price fall below the current annual low of USD 332.01, this is likely to trigger a further sell-off towards the USD 275 mark, the low from 2022.

    However, the valuation argues against a further sell-off and higher price potential, especially after the recently published figures, which included a jump in both sales and earnings. Adobe shares are currently trading at a significant discount. At 17.5, the price-to-earnings ratio is not only around 25% below the industry average of 24.0, but also 45% below its own 5-year average. The same picture is reflected in the price-to-cash-flow ratio. The US company currently stands at 15.6, compared to 18.4 for the industry and 28.2 for the Company's historical average.

    At the same time, however, they also demonstrate Adobe's high cash conversion quality. Thanks to strong cash inflows, the Company can regularly carry out share buybacks worth billions. In the last quarter alone, 8 million shares totaling over USD 2.5 billion were repurchased, a clear sign of financial strength and confidence in the Company's own valuation.


    The AI wave continues to be ridden by investors. The former industry laggard, Adobe, is massively undervalued compared to its peer group. The partnership with OpenAI is giving AMD shares a boost, while NetraMark has successfully secured a far-reaching cooperation agreement.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by André Will-Laudien on October 27th, 2025 | 07:00 CET

    Super returns, clear conscience! Nel ASA and JinkoSolar turn around, nucera surprises, and RE Royalties celebrates!

    • royalties
    • Sustainability
    • renewableenergies
    • Technology
    • GreenTech

    From the climate conference to real implementation! The European Union and other nations have committed themselves to ambitious sustainability programs through so-called "green deals." To support these efforts, the financial instrument known as the "green bond" has become firmly established in the market. Banks, in particular, that are keen to enhance their ESG credentials, are increasingly active in this segment. As a result, the green bond market has grown rapidly, driven by global climate targets, such as those agreed upon in the Paris Agreement. ESG investments are benefiting from political incentives like the US Inflation Reduction Act and are being dynamically sought after by insurers. Between 2015 and 2023, issuances grew by an average of 40% annually, with growth slowing somewhat since 2023. For the full year 2025, total issuance volume is expected to reach between EUR 570 and 630 billion. What, when, and where funding is provided is defined by regulatory authorities. But private organizations such as RE Royalties are also active, because green returns are not only rewarding, they also help society achieve its ambitious climate transition goals. Here are a few investment ideas.

    Read

    Commented by André Will-Laudien on October 24th, 2025 | 07:35 CEST

    BioNxt Solutions advances sublingual MS therapy into decisive development phase

    • Biotechnology
    • Biotech
    • patents
    • Innovations

    BioNxt Solutions is on the verge of a decisive step in the development of its novel sublingual cladribine formulation for the treatment of multiple sclerosis. Following successful small-animal studies, the Company is now launching a large-scale animal study to optimize dosage ahead of the planned human bioequivalence study in 2026. The orally soluble thin-film technology is designed to enable faster drug absorption, greater bioavailability, and easier administration. At the same time, BioNxt is securing patent protection in key global markets, further strengthening its position in the competitive field of advanced drug delivery systems. With its focus on patient-friendly, precise, and effective therapies, BioNxt could set a new standard in MS treatment. A promising setup for the coming months. What opportunities does the Company offer dynamic investors?

    Read

    Commented by Fabian Lorenz on October 24th, 2025 | 07:25 CEST

    Yesterday +16%! D-Wave explodes again! Siemens Energy and First Hydrogen shares benefit from AI's energy hunger

    • Hydrogen
    • cleantech
    • greenhydrogen
    • AI
    • computing
    • Energy

    What a bounce for D-Wave. After a sharp correction yesterday, the quantum stock rose 16%. Is the Trump administration getting involved in quantum companies? That is the rumor making the rounds. Meanwhile, the energy hunger of AI data centers is also keeping the stock market on tenterhooks. One beneficiary from Germany is Siemens Energy. The stock is running like clockwork. Small modular reactors (SMRs) are a huge topic in North America. The Canadian government is providing massive support to industry, which should benefit First Hydrogen. The Company plans to combine its hydrogen expertise with SMR technology. So - buy now?

    Read